Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Polyglutamylation of tubulin's C-terminal tail controls pausing and motility of kinesin-3 family member KIF1A.

Lessard DV, Zinder OJ, Hotta T, Verhey KJ, Ohi R, Berger CL.

J Biol Chem. 2019 Apr 19;294(16):6353-6363. doi: 10.1074/jbc.RA118.005765. Epub 2019 Feb 15.

PMID:
30770469
2.

KIF18A's neck linker permits navigation of microtubule-bound obstacles within the mitotic spindle.

Malaby HL, Lessard DV, Berger CL, Stumpff J.

Life Sci Alliance. 2019 Jan 17;2(1). pii: e201800169. doi: 10.26508/lsa.201800169. Print 2019 Feb.

3.

Tau directs intracellular trafficking by regulating the forces exerted by kinesin and dynein teams.

Chaudhary AR, Berger F, Berger CL, Hendricks AG.

Traffic. 2018 Feb;19(2):111-121. doi: 10.1111/tra.12537. Epub 2017 Dec 5.

4.

Acetylated Microtubules Are Preferentially Bundled Leading to Enhanced Kinesin-1 Motility.

Balabanian L, Berger CL, Hendricks AG.

Biophys J. 2017 Oct 3;113(7):1551-1560. doi: 10.1016/j.bpj.2017.08.009.

5.

Single-molecule imaging of Tau dynamics on the microtubule surface.

Stern JL, Lessard DV, Ali R, Berger CL.

Methods Cell Biol. 2017;141:135-154. doi: 10.1016/bs.mcb.2017.06.016. Epub 2017 Aug 8.

PMID:
28882299
6.

The axonal transport motor kinesin-2 navigates microtubule obstacles via protofilament switching.

Hoeprich GJ, Mickolajczyk KJ, Nelson SR, Hancock WO, Berger CL.

Traffic. 2017 May;18(5):304-314. doi: 10.1111/tra.12478. Epub 2017 Apr 5.

7.

Phosphoregulation of Tau modulates inhibition of kinesin-1 motility.

Stern JL, Lessard DV, Hoeprich GJ, Morfini GA, Berger CL.

Mol Biol Cell. 2017 Apr 15;28(8):1079-1087. doi: 10.1091/mbc.E16-10-0728. Epub 2017 Mar 1.

8.

Kinesin's neck-linker determines its ability to navigate obstacles on the microtubule surface.

Hoeprich GJ, Thompson AR, McVicker DP, Hancock WO, Berger CL.

Biophys J. 2014 Apr 15;106(8):1691-700. doi: 10.1016/j.bpj.2014.02.034.

9.

Tau interconverts between diffusive and stable populations on the microtubule surface in an isoform and lattice specific manner.

McVicker DP, Hoeprich GJ, Thompson AR, Berger CL.

Cytoskeleton (Hoboken). 2014 Mar;71(3):184-94. doi: 10.1002/cm.21163. Epub 2014 Feb 24.

10.

Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy.

Gonzalez AL, Berger CL, Remington J, Girardi M, Tigelaar RE, Edelson RL.

Clin Exp Immunol. 2014 Mar;175(3):449-57. doi: 10.1111/cei.12231.

11.

Kinetics of presynaptic filament assembly in the presence of single-stranded DNA binding protein and recombination mediator protein.

Liu J, Berger CL, Morrical SW.

Biochemistry. 2013 Nov 12;52(45):7878-89. doi: 10.1021/bi401060p. Epub 2013 Oct 30.

12.

Motor domain phosphorylation modulates kinesin-1 transport.

DeBerg HA, Blehm BH, Sheung J, Thompson AR, Bookwalter CS, Torabi SF, Schroer TA, Berger CL, Lu Y, Trybus KM, Selvin PR.

J Biol Chem. 2013 Nov 8;288(45):32612-21. doi: 10.1074/jbc.M113.515510. Epub 2013 Sep 26.

13.

Single-molecule motility: statistical analysis and the effects of track length on quantification of processive motion.

Thompson AR, Hoeprich GJ, Berger CL.

Biophys J. 2013 Jun 18;104(12):2651-61. doi: 10.1016/j.bpj.2013.05.022.

14.

Breaking the millisecond barrier: single molecule motors wobble to find their next binding sites.

Berger CL.

Biophys J. 2013 Mar 19;104(6):1219-20. doi: 10.1016/j.bpj.2013.02.016. Epub 2013 Mar 19. No abstract available.

15.

The nucleotide-binding state of microtubules modulates kinesin processivity and the ability of Tau to inhibit kinesin-mediated transport.

McVicker DP, Chrin LR, Berger CL.

J Biol Chem. 2011 Dec 16;286(50):42873-80. doi: 10.1074/jbc.M111.292987. Epub 2011 Oct 27.

16.

Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients.

Lin WM, Lewis JM, Filler RB, Modi BG, Carlson KR, Reddy S, Thornberg A, Saksena G, Umlauf S, Oberholzer PA, Karpova M, Getz G, Mane S, Garraway LA, Dummer R, Berger CL, Edelson RL, Girardi M.

J Invest Dermatol. 2012 Jan;132(1):188-97. doi: 10.1038/jid.2011.254. Epub 2011 Sep 1.

17.

Loop 1 dynamics in smooth muscle myosin: isoform specific differences modulate ADP release.

Decarreau JA, Chrin LR, Berger CL.

J Muscle Res Cell Motil. 2011 Aug;32(1):49-61. doi: 10.1007/s10974-011-9251-z. Epub 2011 Jun 5.

PMID:
21643973
18.

Switch I closure simultaneously promotes strong binding to actin and ADP in smooth muscle myosin.

Decarreau JA, James NG, Chrin LR, Berger CL.

J Biol Chem. 2011 Jun 24;286(25):22300-7. doi: 10.1074/jbc.M111.219014. Epub 2011 May 2.

19.

Nucleotide pocket thermodynamics measured by EPR reveal how energy partitioning relates myosin speed to efficiency.

Purcell TJ, Naber N, Franks-Skiba K, Dunn AR, Eldred CC, Berger CL, Málnási-Csizmadia A, Spudich JA, Swank DM, Pate E, Cooke R.

J Mol Biol. 2011 Mar 18;407(1):79-91. doi: 10.1016/j.jmb.2010.11.053. Epub 2010 Dec 23.

20.

Fluorescence anisotropy and resonance energy transfer: powerful tools for measuring real time protein dynamics in a physiological environment.

Yengo CM, Berger CL.

Curr Opin Pharmacol. 2010 Dec;10(6):731-7. doi: 10.1016/j.coph.2010.09.013. Epub 2010 Oct 23. Review.

21.

Prediction of blunt traumatic injury in high-acuity patients: bedside examination vs computed tomography.

Smith CB, Barrett TW, Berger CL, Zhou C, Thurman RJ, Wrenn KD.

Am J Emerg Med. 2011 Jan;29(1):1-10. doi: 10.1016/j.ajem.2009.05.025. Epub 2010 Mar 26.

PMID:
20825767
22.

The balance between immunity and tolerance: the role of Langerhans cells.

Mutyambizi K, Berger CL, Edelson RL.

Cell Mol Life Sci. 2009 Mar;66(5):831-40. doi: 10.1007/s00018-008-8470-y. Review.

23.

Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading.

Shen X, Berger CL, Tigelaar R, Edelson RL.

Immunol Invest. 2008;37(8):798-821. doi: 10.1080/08820130802403358.

PMID:
18991097
24.

Cutaneous T cell lymphoma: translating immunobiology into therapeutic opportunities.

Berger CL, Heald P, Girardi M, Edelson RL.

G Ital Dermatol Venereol. 2008 Feb;143(1):43-54. Review.

PMID:
18833050
25.

Intrinsic fluorescence reports a global conformational change in the N-lobe of human serum transferrin following iron release.

James NG, Berger CL, Byrne SL, Smith VC, MacGillivray RT, Mason AB.

Biochemistry. 2007 Sep 18;46(37):10603-11. Epub 2007 Aug 21.

PMID:
17711300
26.

Improved generation of anti-tumor immunity by antigen dose limitation.

Shofner JD, Vasquez JG, Berger CL, Edelson RL.

J Immune Based Ther Vaccines. 2007 Feb 9;5:2.

27.

Transimmunization for cutaneous T cell lymphoma: a Phase I study.

Girardi M, Berger CL, Wilson LD, Christensen IR, Thompson KR, Glusac EJ, Edelson RL.

Leuk Lymphoma. 2006 Aug;47(8):1495-503.

PMID:
16966259
28.

Langerhans cells: mediators of immunity and tolerance.

Berger CL, Vasquez JG, Shofner J, Mariwalla K, Edelson RL.

Int J Biochem Cell Biol. 2006;38(10):1632-6. Epub 2006 Mar 29. Review.

PMID:
16697242
29.

Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphoma.

Wong HK, Wilson AJ, Gibson HM, Hafner MS, Hedgcock CJ, Berger CL, Edelson RL, Lim HW.

J Invest Dermatol. 2006 Jan;126(1):212-9.

30.

Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading.

Salskov-Iversen M, Berger CL, Edelson RL.

J Immune Based Ther Vaccines. 2005 Jul 19;3:4.

31.

Structural rearrangements in the active site of smooth-muscle myosin.

Robertson CI, Gaffney DP 2nd, Chrin LR, Berger CL.

Biophys J. 2005 Sep;89(3):1882-92. Epub 2005 Jun 10.

32.

Kinetics of structural changes in the relay loop and SH3 domain of myosin.

van Duffelen M, Chrin LR, Berger CL.

Biochem Biophys Res Commun. 2005 Apr 8;329(2):563-72.

PMID:
15737623
33.

The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy.

Berger CL, Edelson R.

Curr Cancer Drug Targets. 2004 Nov;4(7):609-19. Review.

PMID:
15578918
34.

Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma.

Berger CL, Mariwalla K, Girardi M, Edelson RL.

Adv Dermatol. 2004;20:217-35. Review. No abstract available.

PMID:
15544202
35.

Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.

Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL.

Blood. 2005 Feb 15;105(4):1640-7. Epub 2004 Oct 28.

36.

Nucleotide dependent intrinsic fluorescence changes of W29 and W36 in smooth muscle myosin.

van Duffelen M, Chrin LR, Berger CL.

Biophys J. 2004 Sep;87(3):1767-75.

38.

Transimmunization, a novel approach for tumor immunotherapy.

Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL.

Transfus Apher Sci. 2002 Jun;26(3):205-16. Review.

PMID:
12126207
39.

Actin-induced closure of the actin-binding cleft of smooth muscle myosin.

Yengo CM, De La Cruz EM, Chrin LR, Gaffney DP 2nd, Berger CL.

J Biol Chem. 2002 Jul 5;277(27):24114-9. Epub 2002 Apr 16.

40.

The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells.

Berger CL, Hanlon D, Kanada D, Dhodapkar M, Lombillo V, Wang N, Christensen I, Howe G, Crouch J, El-Fishawy P, Edelson R.

Blood. 2002 Apr 15;99(8):2929-39.

41.

Fluorescence resonance energy transfer in acto-myosin complexes.

Yengo CM, Berger CL.

Results Probl Cell Differ. 2002;36:21-30. Review. No abstract available.

PMID:
11892281
42.

The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.

Berger CL, Longley J, Hanlon D, Girardi M, Edelson R.

Ann N Y Acad Sci. 2001 Sep;941:106-22.

PMID:
11594564
43.

Induction of human tumor-loaded dendritic cells.

Berger CL, Xu AL, Hanlon D, Lee C, Schechner J, Glusac E, Christensen I, Snyder E, Holloway V, Tigelaar R, Edelson RL.

Int J Cancer. 2001 Feb 15;91(4):438-47.

44.
45.
46.
47.

Dynamics at Lys-553 of the acto-myosin interface in the weakly and strongly bound states.

MacLean JJ, Chrin LR, Berger CL.

Biophys J. 2000 Mar;78(3):1441-8.

48.
49.

Smooth muscle myosin mutants containing a single tryptophan reveal molecular interactions at the actin-binding interface.

Yengo CM, Fagnant PM, Chrin L, Rovner AS, Berger CL.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12944-9.

50.

Supplemental Content

Loading ...
Support Center